Readability tests (testing the readability of package leaflets of medicinal products)

 

The aim of the survey is to make package leaflets of medicines as clear and simple to the patients as possible. During the survey, the following features are determined and improved:

  • Finding necessary information about a drug;
  • Understandability of information;
  • Applicability of information.

When registering a drug, the manufacturer must prove that readability tests of package leaflet have been carried out. The manufacturer must present a package leaflet readability test report to authorities. EU Directive 2001/83/EC as amended by Directive 2004/27/EC provide that a package leaflet must be “legible, clear and easy to use”.

REQUEST FROM WEBSITE:

HEADQUATERS & COMPANY DETAILS
RAIT LTD
Laisvės av. 60, 14fl.
LT-05120 Vilnius, Lietuva
Phone.: +370 5 269 12 47
Fax.: +370 5 269 12 48
E-mail: info@rait.lt
Company code: 125996770
VAT number: LT259967716
Bank: AB SEB
LT68 7044 0600 0162 4109
Bank code: 70440
RAIT LATVIA LTD
Z.A.Meierovica blv. 16-6
LV-1050 Riga, Latvia
Phone.: +371 2 74 34 000
E-mail: info@rait.lv
Company code: 40103816473
VAT number: LV40103816473
Bank: AS SWEDBANK
LV61HABA0 5510 3881 4827
Bank code: HABALV22 
FAKTUM & ARIKO LTD
Tatari str. 64
10134  Tallinn, Estonia
Phone.: +372 611 6018
E-mail: info@faktum-ariko.ee
Company code: 10892011
VAT number:  EE100789195
Bank: Swedbank
EE122200221020676840
Bank code: HABAEE2X 
bigimg
Close

REQUEST FROM WEBSITE: